Sorrento (SRNE) Says Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic Activity in Stage …StreetInsider.comSorrento Therapeutics, Inc. (NASDAQ: SRNE) (“Sorrento”), cellular therapy focused subsidiary, TNK Therapeutics, Inc. (“… Continue reading
STLtoday.com |
First childhood leukemia patient ready for ‘game-changing’ therapy in St. Louis
STLtoday.com Jonathan Cook, 12, of Swansea, Ill., relaxes in his hospital bed during an interview on Tuesday , Feb. 27, 2018, at St. Louis Children’s Hospital. Jonathan will be the first to receive CAR–T cell therapy for recurring leukemia at Children’s Hospital … |
Immuno-Oncology News |
Fate Receives $4 Million to Advance Natural Killer Cell Immunotherapy Into Trials
Immuno-Oncology News At the heart of Fate’s therapy is engineering white blood cells known as natural killer cells to do a better job of killing tumor cells. Natural killer cells play a key role in preventing and eliminating tumor cells. Once immune system antibodies bind … |
Xconomy |
Paying for Gene Therapy, CRISPR in People, RNAi at “What’s Hot” on May 16
Xconomy The first U.S. gene therapy, for a rare form of vision loss, is now on the market. In 2017, the FDA also approved the first two CAR-T cell therapies for cancer, the first cancer drug based on a genetic signature, and the first smartphone app to treat … |
Phys.Org |
Gene editing method produces perfect pluripotent stem cell twins
Phys.Org Single mutations in DNA, known as single nucleotide polymorphisms—or SNPs for short—are the most common type of variation in the human genome. More than 10 million SNPs are known, many of which are associated with ailments such as Alzheimer’s, heart … |